CBT - Page 1 | CARLAT PUBLISHING

Expert Q&A

Targeted Treatment of Depression in Children and Adolescents

October 1, 2025

Joshua Feder, MD

Associate clinical professor, Department of Psychiatry, University of California, San Diego School of Medicine, San Diego, CA; Editor-in-Chief, The Carlat Child Psychiatry Report.

Special thanks to Mara Goverman for facilitating this interview. You can hear more from Ms. Goverman on our podcast, available wherever you get your podcasts.

Depression in children is rarely simple. Dr. Joshua Feder shares how to use a biopsychosocial lens to identify the unique roots of depression—from medical and developmental factors to social stressors—and create targeted, individualized treatment plans for more effective care.

Expert Q&A

Managing School Refusal

October 1, 2025

Raman Marwaha, MD

Associate professor, residency program director, and vice chair of education, Case Western Reserve University; child psychiatrist, Metro Health System; Cleveland, OH.

Dr. Marwaha has no financial relationships with companies related to this material.

School refusal is on the rise post-pandemic. Dr. Raman Marwaha outlines how to distinguish it from truancy, assess underlying anxiety or learning issues, and apply CBT-based graded exposure and family interventions to help students successfully return to school.

Clinical Update

Benzodiazepine Use in Kids and Teens: When Is It Safe, When Is It Effective?

October 1, 2025

Anthony Charuvastra, MD and Tal Tetzeli

Anthony Charuvastra, MD. Assistant professor, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Tal Tetzeli. Research assistant, Department of Child and Adolescent Psychiatry, NYU Langone, New York, NY.

Dr. Charuvastra and Ms. Tetzeli have no financial relationships with companies related to this material.

Are benzodiazepines ever appropriate for children? This evidence-based update explains why SSRIs remain first-line for pediatric anxiety, the rare instances when short-term BZD use makes sense, and the key risks clinicians must weigh—including dependence, interference with therapy, and drug diversion.

Clinical Update

Prescribing Medications for Sleep Disorders in Older Adults

June 12, 2025

Evelina Sterina, MD, MSc, Julia Golden, MD, and Grace Ma, MD

Evelina Sterina, MD, MSc; Julia Golden, MD; Grace Ma, MD. Brigham & Women’s Hospital/Harvard Medical School Psychiatry Residency, Boston, MA.

Drs. Sterina, Golden, and Ma have no financial relationships with companies related to this material.

Sleep disorders affect nearly half of adults over 65, impairing quality of life and increasing risks of cognitive decline, mood disorders, falls, metabolic syndrome, heart disease, stroke, and cancer.

CLINICAL UPDATE

Four Evidence-Based Psychotherapies for PTSD

December 11, 2024

Daniel Carlat, MD

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing. Dr. Carlat has no financial relationships with companies related to this material.

A discussion of four evidence-based therapies for PTSD: prolonged exposure; trauma-focused cognitive behavioral therapy; cognitive processing therapy; and eye movement desensitization and reprocessing.

Clinical Guidance

How to Use Cognitive Behavioral Therapy Techniques for Anxiety Disorders

November 19, 2024

Daniel Carlat, MD

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Cognitive behavioral therapy (CBT) is highly effective for patients with anxiety disorders—but only when patients are motivated and willing to engage in therapeutic exercises and apply coping skills.

PeopleImages.com - Yuri A/shutterstock_2312325595

CLINICAL UPDATE

Pharmacotherapy for Panic Disorder: What Therapists Need to Know

August 6, 2024

Daniel Carlat, MD

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.

Dr. Carlat has no financial relationships with companies related to this material.

An overview of current pharmacotherapy for panic disorder, including the use of antidepressants, benzodiazepines, and emerging treatments like pregabalin, as well as the importance of combining medication with psychotherapy and guidance for therapists when discussing medication concerns with their clients.

Research Update

Therapy in Dementia? Choose CBT

April 1, 2024

Timothy J. Legg, PhD, PsyD, MSN, MPA, MSc

Timothy J. Legg, PhD, PsyD, MSN, MPA, MSc. Dr. Legg has no financial relationships with companies related to this material.

In MCI or dementia, CBT is the only psychological intervention that improves depression, quality of life, and ADLs.

Evidence for Psychodynamic Psychotherapy

December 25, 2023

Mark L. Ruffalo, MSW, DPsa, Jonathan Shedler PhD, and Geneva Valeska

In today’s podcast, we explore background knowledge, experiences, and misconceptions surrounding psychodynamic therapy and discuss how we define evidence for it with our guest, Dr. Jonathan Shedler.

CLINICAL UPDATE

Advances in Trauma-Focused CBT for Child Sexual Abuse

December 20, 2023

Elisabeth S. Pollio, PhD, Melissa J. McLean, MA, LPC, and Esther Deblinger, PhD

Elisabeth S. Pollio, PhD. Associate Professor of Psychiatry, Rowan-Virtua School of Osteopathic Medicine; Director of Mental Health Administration, Child Abuse Research Education and Service (CARES) Institute. Melissa J. McLean, MA, LPC. Mental Health Clinician, Owner, Morning Joy Counseling, LLC. Esther Deblinger, PhD. Professor of Psychiatry, Rowan-Virtua- School of Osteopathic Medicine; Co-Founder, Child Abuse Education Research and Service (CARES) Institute.

Dr. Pollio and Ms. McLean have no financial relationships with companies related to this material. Dr. Deblinger receives royalties as a speaker and co-developer of Trauma-Focused Cognitive Behavior Therapy (TF-CBT) and as an author from Guilford Publications and Oxford University Press. Relevant financial relationships listed for Dr. Deblinger have been mitigated.

TF-CBT can aid recovery of patients after sexual abuse, making it a recommended and extensively supported therapy for practitioners working with individuals impacted by such trauma.